What does PMV Pharmaceuticals, Inc. do?
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor…
What is PMV Pharmaceuticals, Inc.'s P/E and P/B ratio?
PMV Pharmaceuticals, Inc. has a P/E ratio of -0.9 and a P/B ratio of 1.38.
What is PMV Pharmaceuticals, Inc.'s debt-to-equity ratio?
PMV Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.00.
How much does PMV Pharmaceuticals, Inc. owe compared with what it owns?
PMV Pharmaceuticals, Inc. owes $0.13 for every $1 it owns (balance sheet Jun 2026), which is low.
What is PMV Pharmaceuticals, Inc.'s Positivity rank?
PMV Pharmaceuticals, Inc. is ranked #4,038 of 6,774 companies globally and #1,917 of 4,000 in United States on PositoAI, with a Positivity Score of 19,985.
Does PMV Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for PMV Pharmaceuticals, Inc..
Where can I read the latest news about PMV Pharmaceuticals, Inc.?
Recent headlines about PMV Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does PMV Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of PMV Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.